The Metabolic Classroom with Dr. Ben Bikman

📢 Ask Dr. Bikman’s Digital Mind (multilingual):
https://benbikman.com/ben-bikmans-digital-ai-mind

📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com

Most people think of gum disease as a local dental issue, but this lecture reveals a much broader and more consequential reality. Dr. Ben Bikman explains how the mouth serves as a gateway to systemic inflammation, particularly when periodontal disease allows bacteria and their toxic byproducts to enter the bloodstream. Once this happens, oral pathogens—especially P. gingivalis—can drive chronic inflammation, disrupt mitochondrial function, and contribute directly to insulin resistance.

At the mechanistic level, Dr. Bikman outlines several pathways linking oral health to metabolic dysfunction. These include cytokine spillover (where inflammatory signals interfere with insulin signaling), direct degradation of insulin receptors by bacterial enzymes, dysregulation of liver glucose metabolism, and disruption of the gut microbiome. Together, these effects create a persistent inflammatory state that impairs glucose control and increases the risk of type 2 diabetes—even in individuals without obesity.

The lecture also explores the strong epidemiological evidence supporting this connection, including studies showing that treating periodontal disease can significantly improve blood sugar control. Dr. Bikman further connects oral health to cardiovascular disease, highlighting how oral bacteria and endotoxins contribute to atherosclerosis. The takeaway is clear: oral health is not separate from metabolic health—it is a critical and often overlooked component of it.

References:
For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com

NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions.

Ben’s favorite yerba mate and fiber: https://ufeelgreat.com/usa/en/c/1BA884

Exogenous ketones: A high-quality option is the NSF-certified goBHB from Clean Form Nutrition, where you can use the code BEN10 for a 10% discount: https://cleanformnutrition.com/products/go-bhb

Ben’s favorite meal-replacement shake: https://gethlth.com (discount: BEN10)
Hosted on Acast. See acast.com/privacy for more information.

📢 Ask Dr. Bikman’s Digital Mind (multilingual):
https://benbikman.com/ben-bikmans-digital-ai-mind

📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com

Topic:
Ivermectin is a Nobel Prize-winning drug with emerging evidence showing it influences mitochondria, inflammation, and metabolic signaling pathways such as AMPK and FXR. While most data is still preclinical, its consistent mechanisms and strong safety record make it a compelling candidate for further research in cancer and metabolic disease.

Summary:
Ivermectin has become one of the most controversial drugs in recent years, but beneath the political noise lies a compelling scientific story. In this lecture, Dr. Ben Bikman examines ivermectin strictly through the lens of peer-reviewed research, highlighting its origins as a Nobel Prize-winning antiparasitic drug and exploring its expanding role in metabolism, mitochondrial function, inflammation, and cancer biology.

A central theme of the lecture is ivermectin’s impact on mitochondria, particularly its ability to inhibit complex I of the electron transport chain. This disruption creates an energy crisis within cells, activates AMPK, suppresses mTOR signaling, and can ultimately trigger apoptosis in cancer cells. Notably, these effects appear to be selective, with cancer cells showing greater sensitivity than healthy cells. Additional mechanisms—including inhibition of PAK1 and synergy with existing chemotherapy agents—further support ivermectin’s potential as a therapeutic candidate in oncology.

Beyond cancer, ivermectin demonstrates meaningful metabolic effects. It reduces inflammation through suppression of NF-kappaB, activates AMPK, and influences glucose metabolism via FXR signaling. Preclinical studies show improvements in insulin sensitivity, glucose control, liver health, and even adipocyte behavior. While human data is still limited, Dr. Bikman emphasizes that the mechanistic consistency across pathways warrants serious clinical investigation rather than dismissal.

References:
For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com

NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions.

Ben’s favorite yerba mate and fiber: https://ufeelgreat.com/usa/en/c/1BA884

Exogenous ketones: A high-quality option is the NSF-certified goBHB from Clean Form Nutrition, where you can use the code BEN10 for a 10% discount: https://cleanformnutrition.com/products/go-bhb

Ben’s favorite meal-replacement shake: https://gethlth.com (discount: BEN10)
Hosted on Acast. See acast.com/privacy for more information.

📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind

📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com

Topic:
Sleep loss alters key hunger hormones—reducing leptin and increasing ghrelin—while simultaneously activating reward pathways that increase cravings for calorie-dense foods. Because sleep and appetite hormones influence each other in both directions, improving sleep quality may be one of the most powerful tools for regulating hunger and metabolic health.

Summary:
Sleep is often treated as a simple lifestyle choice, but in reality it is one of the most powerful regulators of appetite and metabolic health. In this lecture, Dr. Ben Bikman explains the intricate hormonal relationship between sleep and hunger, highlighting how even short periods of sleep deprivation can dramatically alter the body’s appetite signals. Key hormones such as leptin and ghrelin shift in opposite directions during sleep restriction—satiety signaling declines while hunger signaling increases—creating a biological drive to eat more food.

Ben also explores how sleep deprivation affects additional systems involved in appetite regulation, including the endocannabinoid system, cortisol rhythms, and the brain’s orexin neurons. These changes don’t just increase hunger—they specifically increase cravings for energy-dense, rewarding foods like chips, sweets, and other highly palatable options. Together, these hormonal changes create what researchers describe as an “obesogenic environment,” where the body becomes biologically primed to overeat.

Importantly, the relationship works both ways. Hormones such as leptin and ghrelin also influence sleep quality, while melatonin plays a coordinating role in regulating the entire circadian system. Dr. Bikman concludes by emphasizing that optimizing sleep—especially protecting early-night deep sleep and minimizing artificial light at night—may be one of the most effective interventions for regulating appetite and improving metabolic health.

References:
For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com

NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions.

#SleepAndMetabolism #SleepAndHunger #Ghrelin #Leptin #SleepDeprivation #MetabolicHealth #CircadianRhythm #EndocannabinoidSystem #SleepScience #HormonesAndSleep #InsulinResistance #AppetiteHormones #SleepAndWeightGain #CortisolRhythm #MelatoninScience #SleepQuality #MetabolismMatters #DrBenBikman #MetabolicClassroom #SleepForHealth

Ben’s favorite yerba mate and fiber: https://ufeelgreat.com/usa/en/c/1BA884

Exogenous ketones: A high-quality option is the NSF-certified goBHB from Clean Form Nutrition, where you can use the code BEN10 for a 10% discount: https://cleanformnutrition.com/products/go-bhb

Ben’s favorite meal-replacement shake: https://gethlth.com (discount: BEN10)
Hosted on Acast. See acast.com/privacy for more information.

📢 Ask Dr. Bikman’s Digital Mind (multilingual):
https://benbikman.com/ben-bikmans-digital-ai-mind

📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com

Topic:
Alzheimer’s disease has traditionally been explained by the buildup of amyloid plaques in the brain, but growing evidence suggests this theory does not fully account for the disease or lead to effective treatments. A metabolic perspective proposes that Alzheimer’s may instead be driven by brain insulin resistance, which disrupts neuronal energy metabolism—while the brain’s ability to use ketones as an alternative fuel remains intact, offering potential strategies for prevention and support.

Summary:
For decades, Alzheimer’s disease has largely been understood through the lens of the amyloid plaque hypothesis, which proposes that sticky protein deposits in the brain trigger neurodegeneration and cognitive decline. In this Metabolic Classroom lecture, Ben explains why that theory is increasingly being questioned. He reviews the historical origins of the plaque hypothesis and the repeated failure of drugs designed to remove amyloid plaques to meaningfully improve patient outcomes. The controversy surrounding manipulated data in influential Alzheimer’s research further highlights the need for a new framework to better explain the disease.

Ben then presents a compelling alternative: Alzheimer’s disease as a metabolic disorder driven by brain insulin resistance. Drawing from mechanistic studies, epidemiological data, and genetic insights, he explains how impaired insulin signaling in the brain can disrupt neuronal energy metabolism, increase tau tangles, impair amyloid clearance, and ultimately contribute to neurodegeneration. This concept has led some researchers to refer to Alzheimer’s as “Type 3 diabetes.”

The lecture also explores a hopeful implication of this metabolic framework. While glucose metabolism is impaired in Alzheimer’s brains, research shows that the brain’s ability to use ketones remains intact. This suggests that strategies that improve insulin sensitivity or increase ketone availability—such as carbohydrate restriction, fasting, exercise, or exogenous ketones—may offer promising avenues for prevention or metabolic support.

References:
For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com

NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions.

#AlzheimersDisease #Type3Diabetes #BrainInsulinResistance #MetabolicHealth #InsulinResistance #BrainHealth #CognitiveDecline #DementiaPrevention #KetonesForBrain #KetogenicScience #LowCarbScience #APOE4 #Neurodegeneration #BrainEnergy #MetabolicDisease #PreventAlzheimers #DrBenBikman #MetabolismMatters #Ketones #BrainMetabolism

Ben’s favorite yerba mate and fiber: https://ufeelgreat.com/usa/en/c/1BA884

Exogenous ketones: A high-quality option is the NSF-certified goBHB from Clean Form Nutrition, where you can use the code BEN10 for a 10% discount: https://cleanformnutrition.com/products/go-bhb

Ben’s favorite meal-replacement shake: https://gethlth.com (discount: BEN10)
Hosted on Acast. See acast.com/privacy for more information.

📢 Ask Dr. Bikman’s Digital Mind (multilingual):
https://benbikman.com/ben-bikmans-digital-ai-mind

📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com

Topic:
Metabolic disease is driven more by fat cell size and adipose tissue dysfunction than by total body fat. Ethnicity, genetics, and personal fat storage capacity determine when fat becomes metabolically dangerous.

Summary:
Dr. Bikman explores a profound but underappreciated truth in metabolic health: it is not how much fat you have that determines disease risk — it is how your fat is stored and how large your fat cells become.

Using the metabolic paradox between the United States and Singapore as a starting point, Dr. Bikman explains why populations with dramatically different obesity rates can have nearly identical rates of type 2 diabetes. The key insight is that fat mass alone does not determine metabolic health. Instead, the size of individual fat cells and the body’s capacity to safely expand subcutaneous fat storage — what’s called the adipose expandability hypothesis — determines whether fat becomes harmful.

White adipose tissue can expand in two ways: hypertrophy or hyperplasia. Hypertrophic fat cells become insulin resistant, release excessive free fatty acids even in the presence of insulin, promote ectopic fat deposition in the liver, and trigger chronic inflammation through hypoxia and HIF-1α signaling. This cascade drives fatty liver disease, systemic insulin resistance, and eventually type 2 diabetes.

By contrast, hyperplastic expansion allows fat to be stored safely in small, metabolically healthy fat cells with normal vascularity and hormone signaling. This distinction explains why some individuals can carry more total fat yet remain metabolically healthy.

Next is the concept of a personal fat threshold, largely influenced by genetics and ethnicity. South and East Asian populations tend to have a lower threshold for safe subcutaneous fat storage, meaning metabolic dysfunction can occur at lower BMIs compared to Europeans or Africans. This makes universal BMI cutoffs inadequate for assessing risk across ethnic groups.

Finally, he discusses two more academic but mechanistically precise markers of fat cell health: the adiponectin-to-leptin ratio and the Adipo-IR index (fasting insulin × fasting free fatty acids).

The takeaway: metabolic risk is determined by fat cell biology, not simply fat mass.

References:
For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com

Timestamps (approximate):
01:00 — The U.S.–Singapore Metabolic Paradox
04:22 — Hypertrophy vs. Hyperplasia: Why Fat Cell Size Matters
07:52 — Insulin’s Anti-Lipolytic Role & Free Fatty Acids
10:04 — When High Insulin and High FFAs Coexist
12:19 — Ectopic Fat, Fatty Liver & the Diabetes Cascade
15:21 — Hypoxia, HIF-1α & Inflammatory Fat Cells
21:15 — The Adipose Expandability Hypothesis
25:40 — The Personal Fat Threshold Explained
32:06 — Why Universal BMI Cutoffs Fail
37:54 — The Adipo-IR Index & Measuring Fat Cell Dysfunction

NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions.

Ben’s favorite yerba mate and fiber: https://ufeelgreat.com/usa/en/c/1BA884

Exogenous ketones: A high-quality option is the NSF-certified goBHB from Clean Form Nutrition, where you can use the code BEN10 for a 10% discount: https://cleanformnutrition.com/products/go-bhb

Ben’s favorite meal-replacement shake: https://gethlth.com (discount: BEN10)
Hosted on Acast. See acast.com/privacy for more information.